Tarsus Pharmaceuticals, Inc.

Q2 2022 13F Holders

Symbol: TARS
CUSIP: 87650L103
Type: Equity
Class: COM
Num filings: 76
Total reported value, excl. options: $292 M

Compare 2022 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type